Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 30;3(Suppl):132-134.
doi: 10.1097/HS9.0000000000000218. eCollection 2019 Jun.

The impact of spliceosome mutations in MDS

Jacqueline Boultwood  1 , Andrea Pellagatti  1
Affiliations

The impact of spliceosome mutations in MDS

Jacqueline Boultwood et al. Hemasphere. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart showing the different steps through which splicing factor mutations may lead to myelodysplastic syndromes.
See this image and copyright information in PMC

References

    1. Pellagatti A, Boultwood J. Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications. Adv Biol Regul 2017; 63:59–70. - PubMed
    1. Saez B, Walter MJ, Graubert TA. Splicing factor gene mutations in hematologic malignancies. Blood 2017; 129:1260–1269. - PMC - PubMed
    1. Papaemmanuil E, Cazzola M, Boultwood J, et al. . Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365:1384–1395. - PMC - PubMed
    1. Yoshida K, Sanada M, Shiraishi Y, et al. . Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478:64–69. - PubMed
    1. Papaemmanuil E, Gerstung M, Malcovati L, et al. . Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122:3616–3627. - PMC - PubMed